KIŞ, M. And GÜZEL, T. 2022. Hemoglobin A1c is a Predictor of Poor Collateral Development in Non-Diabetic Patients with Coronary Chronic Total Occlusion: Retrospective Clinical Trial. TURKIYE KLINIKLERI CARDIOVASCULAR SCIENCES , vol.34, no.2 , 62-68.

KIŞ, M., & GÜZEL, T., (2022). Hemoglobin A1c is a Predictor of Poor Collateral Development in Non-Diabetic Patients with Coronary Chronic Total Occlusion: Retrospective Clinical Trial. TURKIYE KLINIKLERI CARDIOVASCULAR SCIENCES , vol.34, no.2, 62-68.

KIŞ, MEHMET, And TUNCAY GÜZEL. "Hemoglobin A1c is a Predictor of Poor Collateral Development in Non-Diabetic Patients with Coronary Chronic Total Occlusion: Retrospective Clinical Trial," TURKIYE KLINIKLERI CARDIOVASCULAR SCIENCES , vol.34, no.2, 62-68, 2022

KIŞ, MEHMET And GÜZEL, TUNCAY. "Hemoglobin A1c is a Predictor of Poor Collateral Development in Non-Diabetic Patients with Coronary Chronic Total Occlusion: Retrospective Clinical Trial." TURKIYE KLINIKLERI CARDIOVASCULAR SCIENCES , vol.34, no.2, pp.62-68, 2022

KIŞ, M. And GÜZEL, T. (2022) . "Hemoglobin A1c is a Predictor of Poor Collateral Development in Non-Diabetic Patients with Coronary Chronic Total Occlusion: Retrospective Clinical Trial." TURKIYE KLINIKLERI CARDIOVASCULAR SCIENCES , vol.34, no.2, pp.62-68.

@article{article, author={MEHMET KIŞ And author={TUNCAY GÜZEL}, title={Hemoglobin A1c is a Predictor of Poor Collateral Development in Non-Diabetic Patients with Coronary Chronic Total Occlusion: Retrospective Clinical Trial}, journal={TURKIYE KLINIKLERI CARDIOVASCULAR SCIENCES}, year=2022, pages={62-68} }